Skip to main content
Article thumbnail
Location of Repository

Circulating plasma factors induce tubular and glomerular alterations in septic burns patients

By Filippo Mariano, Vincenzo Cantaluppi, Maurizio Stella, Giuseppe Mauriello Romanazzi, Barbara Assenzio, Monica Cairo, Luigi Biancone, Giorgio Triolo, V Marco Ranieri and Giovanni Camussi
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1988). A: A study of renal damage in seriously burned patients. Burns
    2. (2004). Acute renal failure and sepsis.
    3. (1982). AL: Patterns of urinary protein excretion in patients with sepsis. Nephron
    4. (1992). American College of Chest Physicians Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med
    5. (1979). Batstone GF: Urine proteins after burn injury. Clin Chim Acta
    6. (2005). BP: Tumor necrosis factor-alpha-induced caspase activation mediates endotoxin-related cardiac dysfunction. Crit Care Med
    7. C: Managing septic acute renal failure: "fill and spill"? "Squeeze and diurese"? or "block Bax to the max"? Crit Care Resusc
    8. (2002). C: The pathogenesis of septic acute renal failure. Curr Opin Crit Care
    9. (2002). Camusi G: Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells.
    10. (1998). Camussi G: HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation.
    11. (2001). Camussi G: Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.
    12. (1999). Camussi G: Production of platelet-activating factor in patients with sepsis-associated acute renal failure. Nephrol Dial Transplant
    13. (2000). Camussi G: Role of platelet-activating factor in functional alterations induced by xenoreactive antibodies in porcine endothelial cells. Transplantation
    14. (1986). Chinitz JL: Continuous arteriovenous hemofiltration for the treatment of anasarca and acute renal failure in severely burned patients. ASAIO Trans
    15. (2007). Chung CS: Blockade of apoptosis as a rational therapeutic strategy for the treatment of sepsis. Novartis Found Symp
    16. (2007). CM: Interleukin-1 mediates thermal injury-induced lung damage through C-Jun NH2-terminal kinase signaling. Crit Care Med
    17. (1999). DN: Acute renal dysfunction in severely burned adults.
    18. (1999). Evans TJ: Inflammatory cytokines induce apoptotic and necrotic cell shedding from human proximal tubular epithelial cell monolayers. Kidney Int
    19. (2006). Hao CM: Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes.
    20. (2005). Heneka MT: Systemic inflammation induces apoptosis with variable vulnerability of different brain regions.
    21. (2006). Hereditary proteinuria syndromes and mechanisms of proteinuria.
    22. (2006). HJ: Tight junction biology and kidney dysfunction.
    23. (1997). IE: Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med
    24. (2003). IE: The pathophysiology and treatment of sepsis.
    25. (2000). Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells.
    26. (2002). JL: Time course of platelet counts in critically ill patients. Crit Care Med
    27. (2000). La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet
    28. (1983). Meadows T: Urinary protein profiles after burn injury. Burns
    29. (2001). Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule.
    30. (2006). MG: Cytokine expression profile over time in severely burned pediatric patients. Shock
    31. (1999). Mühlbauer W: Acute renal failure in severely burned patients. Burns
    32. (2002). NH: Inflammatory cytokines and lipopolysaccharide induce Fasmediated apoptosis in renal tubular cells. Nephron
    33. (1979). Nishikaze O: New micro-turbidimetric method for determination of protein in cerebrospinal fluid and urine. Clin Chem
    34. (2006). Pal SK: Correlation of microalbuminuria and outcome in patients with extensive burns.
    35. (2004). Palevsky P on behalf of the Acute Dialysis Quality Initiative workgroup: Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs:
    36. (2005). Platelets in sepsis. Hematology
    37. (1996). Prough DS: Critical care of burn complications.
    38. (1995). PS: Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
    39. (1997). Querin S: Continuous hemofiltration ad hemodiafiltration for acute renal failure in severely burned patients. Burns
    40. (2002). RJ: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney.
    41. (2003). Sato S: Examination of soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients with burns. Burns
    42. (2003). Slutsky AS: Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA
    43. (1999). Tompkins RG: Objective estimates of the probability of death from burn injuries.
    44. (2004). Triolo G: Regional citrate anticoagulation in critically ill patients treated with plasma filtration and adsorption. Blood Purif
    45. (2000). Veno-venous continuous renal replacement therapy for burned patients with acute renal failure. Burns

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.